Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 15/20 | 0.65 |
| ▸ | PTGES | O14684 | 2/20 | 0.65 |
| ▸ | PNLIP | P16233 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.47 |
| ▸ | BCL9 | O00512 | 3/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Epiisorosmanol SCHEMBL29511557 | 1.00 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Isorosmanol SCHEMBL14599481 | 1.00 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Isorosmanol SCHEMBL12574307 | 1.00 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| SCHEMBL12969255 | 0.91 | FDPS (0.54) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL459610 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Epirosmanol SCHEMBL3272202 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL28962181 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Epirosmanol SCHEMBL29426648 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL13062163 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| SCHEMBL4194868 | 0.82 | FDPS (0.59) | FDPSPTGESPNLIPMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250360178-A1 | ORGANIC PAIN RELIEF AND HAIR GROWTH COMPOSITION | THE TAO TALIT CORP (US) | 2025-11-27 | — | — | US | claimed |
| US-12383593-B2 | Organic pain relief and hair growth composition | The Tao Talit Corporation | 2025-08-12 | — | — | US | claimed |
| EP-4518685-A1 | METHOD OF PREVENTING AND/OR INHIBITING THE OUTGROWTH, SPORULATION, GERMINATION OR TOXIN FORMATION OF CLOSTRIDIUM | Givaudan SA (CH) | 2025-03-12 | — | — | EP | claimed |
| EP-4514153-A1 | COMPOSITION AND METHOD FOR REDUCING THE AMOUNT OF ACRYLAMIDE IN FOOD | Givaudan SA (CH) | 2025-03-05 | — | — | EP | claimed |
| WO-2023208753-A1 | COMPOSITION AND METHOD FOR REDUCING THE AMOUNT OF ACRYLAMIDE IN FOOD | GIVAUDAN SA (CH) | 2023-11-02 | — | — | WO | claimed |
| US-20230337668-A1 | COMPOSITION | GIVAUDAN SA (CH) | 2023-10-26 | — | — | US | claimed |
| CN-116600646-A | Preservative and antimicrobial compositions | 奇华顿股份有限公司 | 2023-08-15 | — | — | CN | claimed |
| EP-4213630-A2 | PRESERVATIVE AND ANTIMICROBIAL COMPOSITIONS | Givaudan SA (CH) | 2023-07-26 | — | — | EP | claimed |
| EP-3378506-B1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | LUTONIX INC (US) | 2023-06-07 | — | — | EP | claimed |
| WO-2023021082-A1 | COMPOSITION | GIVAUDAN SA (CH) | 2023-02-23 | — | — | WO | claimed |
| US-20220401506-A1 | ORGANIC PAIN RELIEF AND HAIR GROWTH COMPOSITION | The Tao Talit Corporation (US) | 2022-12-22 | — | — | US | claimed |
| WO-2022058343-A2 | COMPOSITION | GIVAUDAN SA (CH) | 2022-03-24 | — | — | WO | claimed |
| US-20260123657-A1 | COMPOSITIONS AND METHODS FOR MASKING OFF-NOTES IN CONSUMABLES | GIVAUDAN SA (CH) | 2026-05-07 | — | — | US | disclosed |
| WO-2026087310-A1 | COMPOSITION, CONSUMABLE AND METHODS | GIVAUDAN SA (CH) | 2026-04-30 | — | — | WO | disclosed |
| EP-4698598-A1 | BETALAIN COMPOSITIONS | Givaudan SA (CH) | 2026-02-25 | — | — | EP | disclosed |
| US-12557793-B2 | Bee feeder having labyrinthine passages | TURTLE BEAR HOLDINGS, LLC (US) | 2026-02-24 | — | — | US | disclosed |
| US-7728043-B2 | Methods for treatment of beta-amyloid protein-induced ocular disease | KIM DARRICK S H L | 2010-06-01 | — | — | US | disclosed |
| US-7728043-B2 | Methods for treatment of beta-amyloid protein-induced ocular disease | KIM DARRICK S H L | 2010-06-01 | — | — | US | disclosed |
| US-20070003641-A1 | Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease | KIM DARRICK S H | 2007-01-04 | — | — | US | disclosed |
| US-20070003641-A1 | Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease | KIM DARRICK S H | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070003641-A1 | Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease | APP, BACE1, GSAP | FDPS 2904/4885PTGES 197/4885PNLIP 3710/4885 |
| US-20260123657-A1 | COMPOSITIONS AND METHODS FOR MASKING OFF-NOTES IN CONSUMABLES | RBP4, RBP1, PROC | FDPS 1706/4885PTGES 1280/4885PNLIP 333/4885 |
| US-12557793-B2 | Bee feeder having labyrinthine passages | WAPL, SARAF, KISS1R | FDPS 2332/4885PTGES 2241/4885PNLIP 3479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.